Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|July 4, 2025
Health-Related Quality of Life in Patients Treated for Nonmetastatic Muscle-Invasive Bladder Cancer: Radical Cystectomy Versus Bladder-Preserving TherapyKatharina Brück, Vera Atema, Annemarie M Leliveld, et al.Science Translational Medicine|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-GuérinFlorus C de Jong, Teemu D Laajala, Robert F Hoedemaeker, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 15, 2017
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapiesNathalie van den Tempel, Hanny Odijk, Netteke van Holthe, et al.The Lancet. Oncology|May 29, 2021
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 studyArjun V Balar, Ashish M Kamat, Girish S Kulkarni, et al.The Journal of Urology|January 28, 2020
A Urine Based Genomic Assay to Triage Patients with Hematuria for CystoscopyKim E M van Kessel, Joep J de Jong, Angelique C J Ziel-van der Made, et al.Molecular Oncology|September 8, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancerGeertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cellsMaud Rijnders, Hayri E Balcioglu, Debbie G J Robbrecht, et al.World Journal of Urology|July 1, 2021
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survivalFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.European Urology|March 14, 2020
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder CancerAndrea Necchi, Daniele Raggi, Andrea Gallina, et al.Journal for Immunotherapy of Cancer|January 24, 2023
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infectionsJelmer H van Puffelen, Boris Novakovic, Liesbeth van Emst, et al.Pageof 11